RPG Life Sciences Key Ratios
NSE: RPGLIFE | BSE: 532983
₹2,627.50
As on 19-Nov-2026 13:44IST
Market cap
₹4,325 Cr
Revenue (TTM)
₹764 Cr
P/E Ratio
39.5
P/B Ratio
6.3
Div. Yield
0.9 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -1.18 | 6.45 | 11.94 | 10.66 | 12.11 |
| EBIT | -28.11 | -19.88 | -1.31 | 8.67 | 13.63 |
| Net Profit | -23.81 | -18.25 | 0.01 | 12.92 | 17.81 |
| EPS | -23.81 | -36.80 | -50.84 | 11.00 | 16.61 |
| Book Value | -- | -- | 14.11 | 25.32 | 22.84 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Mar-26 | Mar-25 |
| EBIT-Margin
| 19.40 | 18.32 | 17.33 | 17.88 | 21.05 |
| Net Margin
| 19.34 | 16.54 | 14.07 | 15.71 | 27.44 |
| Return on equity
| 28.82 | 26.45 | 17.79 | 20.28 | 34.54 |
| Return on Capital
| 37.91 | 35.62 | -- | 26.99 | 44.20 |
| Return on Assets
| 22.02 | 19.93 | 19.89 | 15.89 | 27.90 |
| Debt to Equity (x)
| -- | -- | 0.00 | 0.03 | 0.00 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
RPG Life Sciences
|
--
|
26.99
|
44.20
|
--
|
--
|
|
Peer Median
|
--
|
12.41
|
16.46
|
15.49
|
--
|
ROE
17.79
Higher than Peers by 8.71
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
RPG Life Sciences
|
17.79
|
20.28
|
34.54
|
--
|
--
|
|
Peer Median
|
9.08
|
13.36
|
13.87
|
14.72
|
--
|
ROA
19.89
Higher than Peers by 12.62
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
RPG Life Sciences
|
19.89
|
15.89
|
27.90
|
--
|
--
|
|
Peer Median
|
7.27
|
7.23
|
8.04
|
7.19
|
--
|
EBIT Margin
17.33
Higher than Peers by 8.09
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
RPG Life Sciences
|
17.33
|
17.88
|
21.05
|
--
|
--
|
|
Peer Median
|
9.25
|
17.33
|
10.05
|
10.28
|
--
|
Net Margin
14.07
Higher than Peers by 5.61
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
RPG Life Sciences
|
14.07
|
15.71
|
27.44
|
--
|
--
|
|
Peer Median
|
8.46
|
11.16
|
9.11
|
6.78
|
--
|
Cash Profit Margin
--
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
RPG Life Sciences
|
--
|
18.06
|
29.21
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
14.68
Higher than Peers by 8.05
Year on year growth in net sales
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
RPG Life Sciences
|
14.68
|
8.28
|
--
|
--
|
--
|
|
Peer Median
|
6.64
|
26.57
|
7.17
|
10.56
|
--
|
EBIT Growth
3.53
Higher than Peers by 3.84
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
RPG Life Sciences
|
3.53
|
-8.03
|
--
|
--
|
--
|
|
Peer Median
|
-0.31
|
31.63
|
12.05
|
6.17
|
--
|
Net Profit Growth
0.01
Lower than Peers by 7.57
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
RPG Life Sciences
|
0.01
|
-37.15
|
--
|
--
|
--
|
|
Peer Median
|
7.58
|
26.27
|
22.15
|
27.97
|
--
|
EPS Growth
-50.84
Lower than Peers by 51.93
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
RPG Life Sciences
|
-50.84
|
-37.15
|
--
|
--
|
--
|
|
Peer Median
|
1.08
|
24.54
|
8.80
|
--
|
--
|
Book Value Growth
--
--
Year on year growth in book value per share
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
RPG Life Sciences
|
--
|
14.10
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
0.00
Lower than Peers by 0.02
Total debt / Net worth
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
RPG Life Sciences
|
0.00
|
0.03
|
--
|
--
|
--
|
|
Peer Median
|
0.02
|
0.17
|
0.03
|
0.05
|
--
|
Current Ratio
2.92
Higher than Peers by 0.53
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
RPG Life Sciences
|
2.92
|
3.48
|
3.88
|
--
|
--
|
|
Peer Median
|
2.40
|
2.09
|
2.20
|
1.93
|
--
|
Quick Ratio
2.17
Higher than Peers by 0.46
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
RPG Life Sciences
|
2.17
|
2.71
|
3.11
|
--
|
--
|
|
Peer Median
|
1.71
|
1.62
|
1.72
|
1.59
|
--
|
Interest Coverage
71.06
Higher than Peers by 61.26
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
RPG Life Sciences
|
71.06
|
88.12
|
147.47
|
--
|
--
|
|
Peer Median
|
9.79
|
10.26
|
12.28
|
12.45
|
--
|
Operating Efficiency
Debtors to sales
18.50
Lower than Peers by 8.54
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
RPG Life Sciences
|
18.50
|
16.49
|
13.28
|
--
|
--
|
|
Peer Median
|
27.04
|
32.97
|
26.23
|
23.97
|
--
|
Asset Turnover
1.37
Higher than Peers by 0.68
Sales / Average Total Assets
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
RPG Life Sciences
|
1.37
|
1.04
|
1.07
|
--
|
--
|
|
Peer Median
|
0.69
|
0.65
|
0.74
|
0.88
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
RPG Life Sciences
|
--
|
49.08
|
45.20
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
RPG Life Sciences
|
--
|
52.31
|
48.44
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
RPG Life Sciences
|
--
|
138.22
|
147.35
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
RPG Life Sciences
|
--
|
-36.84
|
-53.72
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
39.54
Lower than Peers by 0.99
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
RPG Life Sciences
|
39.54
|
26.57
|
20.56
|
--
|
--
|
|
Peer Median
|
40.53
|
41.56
|
39.17
|
40.74
|
--
|
Price / Book Value
6.29
Higher than Peers by 2.63
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
RPG Life Sciences
|
6.29
|
5.05
|
7.10
|
--
|
--
|
|
Peer Median
|
3.66
|
4.55
|
3.61
|
3.87
|
--
|
Dividend Yield
0.92
Higher than Peers by 0.81
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
RPG Life Sciences
|
0.92
|
1.30
|
1.05
|
--
|
--
|
|
Peer Median
|
0.11
|
0.11
|
0.19
|
0.20
|
--
|
EV/EBITDA
23.29
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
RPG Life Sciences
|
23.29
|
16.64
|
20.93
|
--
|
--
|
|
Peer Median
|
--
|
38.58
|
28.79
|
25.41
|
--
|
Market Cap
4,325
Lower than Peers by 730
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
RPG Life Sciences
|
4,325
|
3,060
|
3,767
|
--
|
--
|
|
Peer Median
|
5,055
|
5,055
|
3,944
|
2,959
|
--
|